Abstract: An acid addition salt of a nortriptyline-GABA conjugate, a novel crystalline form of a fumaric acid addition salt of a nortriptyline-GABA conjugate, and processes of preparing the forgoing are disclosed. Uses of the above-indicated forms of a nortriptyline-GABA conjugate in the treatment of CNS disorders, and in the treatment of pain in particular, are also disclosed. Further disclosed in a large-scale process of preparing a nortriptyline-GABA conjugate.
Type:
Grant
Filed:
September 22, 2011
Date of Patent:
December 23, 2014
Assignees:
Ramot at Tel-Aviv University Ltd., Bar-Ilan University
Inventors:
Abraham Nudelman, Ada Rephaeli, Irit Gil-Ad, Abraham Weizman, Mazal Shaul, Efrat Halbfinger
Abstract: A method for processing communication traffic includes receiving an incoming stream of compressed data conveyed by a sequence of data packets, each containing a respective portion of the compressed data. The respective portion of the compressed data contained in the first packet is stored in a buffer, having a predefined buffer size. Upon receiving a subsequent packet, at least a part of the compressed data stored in the buffer and the respective portion of the compressed data contained in the subsequent packet are decompressed, thereby providing decompressed data. A most recent part of the decompressed data that is within the buffer size is recompressed and stored in the buffer.
Type:
Grant
Filed:
March 20, 2012
Date of Patent:
December 9, 2014
Assignees:
Ramot at Tel-Aviv University Ltd., Interdisciplinary Center Herzliya
Abstract: Use of homogeneous catalytic systems which include as a pre-catalyst a complex of a Group IV metal and a salalen ligand in the polymerization of alpha-olefins, is disclosed. The alpha-olefin polymers obtained are characterized by controlled levels of tacticity. Also disclosed are novel salalen ligands and novel complexes thereof with Group IV metals.
Abstract: An insulin degrading enzyme (IDE) inhibitor for use in the treatment of a disease selected from the group consisting of an autoimmune disease of the central nervous system and a neurodegenerative disease is disclosed.
Abstract: An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell. Methods of generating same and uses of same are also disclosed.
Type:
Grant
Filed:
January 27, 2014
Date of Patent:
December 2, 2014
Assignees:
Ramot at Tel-Aviv University Ltd., BrainStorm Cell Therapeutics Ltd.
Abstract: A method of processing a computerized tomography image is disclosed. The method comprises preprocessing the image using contrast enhancement weight function, thereby providing a preprocessed image having a first dynamic range; and applying a companding procedure to the preprocessed image, so as to reduce the first dynamic range.
Abstract: Disclosed are methods and devices useful for imaging blood-containing tissue, for example for angiography, especially retinal angiography, whereby an image is generated by dividing pixels of an image acquired at some wavelength range by corresponding pixels of an image acquired at a different wavelength range. In some embodiments, a first wavelength range includes predominantly light having wavelengths between about 400 nm and about 620 nm and a second wavelength range includes predominantly light having wavelengths between about 620 nm and about 800 nm.
Type:
Application
Filed:
February 8, 2012
Publication date:
November 20, 2014
Applicants:
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., RAMOT AT TEL AVIV UNIVERSITY LTD.
Inventors:
Genady KOSTENICH, Arie ORENSTEIN, Michael BELKIN
Abstract: An oscillatory vorticity generator device for controlling the flow on an aero- or hydrodynamic surface of an element, the oscillatory vorticity generator device comprising: two main walls, positioned opposite to each other, forming a first pair of walls and two other walls, the four walls each having proximal and distal ends, the distal ends connected to an aero- or hydrodynamic surface; a connection connecting the walls at their proximal ends; and an opening in the aero- or hydrodynamic surface, the opening being substantially contiguous with the two main walls and the two other walls.
Type:
Grant
Filed:
November 23, 2010
Date of Patent:
November 4, 2014
Assignee:
Ramot at Tel-Aviv University Ltd.
Inventors:
Avraham Seifert, Oksana Stalnov, Ilan Fono, Isaac Dayan, Victor Troshin, Maor Hai Avnaim, Vitali Palei
Abstract: Data clustering is provided according to a dynamical framework based on quantum mechanical time evolution of states corresponding to data points. To expedite computations, we can approximate the time-dependent Hamiltonian formalism by a truncated calculation within a set of Gaussian wave-functions (coherent states) centered around the original points. This allows for analytic evaluation of the time evolution of all such states, opening up the possibility of exploration of relationships among data-points through observation of varying dynamical-distances among points and convergence of points into clusters. This formalism may be further supplemented by preprocessing, such as dimensional reduction through singular value decomposition and/or feature filtering.
Type:
Grant
Filed:
September 15, 2009
Date of Patent:
October 28, 2014
Assignees:
The Board of Trustees of the Leland Stanford Junior University, Ramot at Tel Aviv University Ltd.
Abstract: A genetically modified bacteriophage is disclosed which comprises: (i) an exogenous polynucleotide which encodes an agent which reduces the toxicity of a bacterium; and (ii) an exogenous polynucleotide which encodes a selectable marker. Uses thereof and kits comprising same are also disclosed.
Abstract: A method of mapping a collection of images, or other higher dimensional items including text documents, and three-and-higher dimensional objects, onto a navigable grid for browsing via a user interface comprises obtaining for each of the images a list of nearest neighbor images and similarity scores for each nearest neighbor; placing a first image on a cell within a grid; from a respective list of nearest neighbors of said first image, finding images that maximize a compatibility score with images already placed on the grid and placing resulting images on neighboring cells; and continuing to place further images on the grid until all cells visible to a user are filled with images. As the user pans or zooms the grid, more cells move into the visible area of the screen and are filled with images in the same way.
Abstract: A tunable tilting device is described. The device includes a tilting element and a suspension structure that has one or more flexures coupled to the tilting element. The suspension structure has a variable bending stiffness and configured to bend due to a tilting motion of the tilting element around a pivot axis. The suspension structure is responsive to a tuning force actuating a variation of an extension stress or a compression stress of the suspension structure, and thereby can vary the bending stiffness of the suspension structure.
Abstract: The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
Type:
Application
Filed:
October 10, 2012
Publication date:
September 18, 2014
Applicants:
RAMOT AT TEL-AVIV UNIVERSITY LTD., CCAM BIOTHERAPEUTICS LTD.
Inventors:
Gal Markel, Tehila Ben Moshe, Yair Sapir, Ilana Mandel, Jacob Schachter, Rona Ortenberg
Abstract: Catalysts comprising Salan ligands with bridged or unbridged diphenyl amine moieties. Also, catalyst systems comprising the catalyst and an activator; methods to prepare the ligands, catalysts and catalyst systems; processes to polymerize olefins using the catalysts and/or catalyst systems; and the olefin polymers prepared according to the processes.
Type:
Application
Filed:
November 11, 2013
Publication date:
September 18, 2014
Applicants:
Ramot at Tel-Aviv University Ltd., ExxonMobil Chemical Patents Inc.
Inventors:
Matthew W. Holtcamp, Meagan E. Evans, David A. Cano, Eric D. Whetmore, Gregory S. Day, Moshe Kol
Abstract: A radiotherapy method, comprising positioning a predetermined amount of a radionuclide selected from the group consisting of Radium-223, Radium-224, Radon-219 and Radon-220, in proximity to and/or within a tumor of a subject, for a predetermined time period. The predetermined amount and the predetermined time period are selected sufficient for the radionuclide to administering a predetermined therapeutic dose of decay chain nuclei and alpha particles into the tumor.
Abstract: A method of measuring a metabolic activity (MA) of a cell is provided. The method comprising independently measuring in an extracellular environment of the cell, time-dependent acidification profiles due to secretion of: (i) non-volatile soluble metabolic products; (ii) non-volatile soluble metabolic products and volatile soluble metabolic products; and (iii) volatile soluble metabolic products; wherein at least one of the time dependent acidification profiles is indicative of the metabolic activity of the cell. Also provided are clinical methods which make use of the assay.
Type:
Application
Filed:
May 18, 2014
Publication date:
September 11, 2014
Applicant:
Ramot at Tel-Aviv University Ltd.
Inventors:
Reuven TIROSH, Fernando Patolsky, Hagit Peretz-Soroka
Abstract: The invention provides novel compounds and pharmaceutical compositions for the treatment of psychological and/or psychiatric diseases or disorders.
Abstract: Data bits to be encoded are split into a plurality of subgroups. Each subgroup is encoded separately to generate a corresponding codeword. Selected subsets are removed from the corresponding codewords, leaving behind shortened codewords, and are many-to-one transformed to condensed bits. The final codeword is a combination of the shortened codewords and the condensed bits. A representation of the final codeword is decoded by being partitioned to a selected subset and a plurality of remaining subsets. Each remaining subset is decoded separately. A subset whose decoding is terminated is decoded again, at least in part according to the selected subset. If the encoding and decoding are systematic then the selected subsets are of parity bits.
Type:
Grant
Filed:
February 21, 2008
Date of Patent:
September 9, 2014
Assignee:
Ramot at Tel Aviv University Ltd.
Inventors:
Simon Litsyn, Eran Sharon, Idan Alrod, Menahem Lasser